Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Political Calculations (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

S&P 500 Falls as Investors Get Spooked by High Costs of AI

% of readers think this story is Fact. Add your two cents.


An editorial cartoon of a Wall Street bull taking cover under a table as a few balloons labeled 'AI' begin to pop while a smiling bear loads a dart labeled 'COSTS' into a blowgun. Image generated with Microsoft Copilot Designer.

Compared to the previous week, the S&P 500 (Index: SPX) didn’t change much in the trading week ending on Friday, 30 October 2026. The index closed out the week at 7,580.07, down a little under 0.6% from where it closed the preceding week.

But that doesn’t quite capture what happened. Stock prices rose the first three days of the week. And then, after the bell on Wednesday, 28 September 2026, tech giant Alphabet (NASDAQ: GOOG and GOOGL) reported not just that they were burning through cash to build up their Artificial Intelligence (AI) infrastructure, their advertising revenue from Internet searches was lower than expected, as their AI-based search feature underperformed expectations.

That was enough to deflate the company’s stock by 12% on Thursday, 29 October 2026, which in turn, contributed to pulling the S&P 500 down by 0.3% for the day. But then after the market closed on Thursday, Amazon (NASDAQ: AMZN) and Intel (NASDAQ: INTC) delivered bad news of higher costs and falling revenues.

Of the two, Intel had the worst of it, with its stock plunging by over 28% by the time markets closed on Friday. More significantly, their combined bad news prompted investors to tank the stock prices of other chipmakers. Including the biggest company in the S&P 500, Nvidia (NASDAQ: NVDA), which lost over 4% of its value and became the second-biggest company in the index as a result by the end of the day.

By the end of the day, the S&P 500 lost over 1.8% of its total value. The latest update of the alternative futures chart shows the index’ trajectory dropped to be near the bottom of the typical range the dividend futures-based model would place it assuming investors are focused on the current quarter of 2026-Q4 in setting stock prices.

Alternative Futures - S&P 500 - 2026Q4 - Standard Model (m=-2.0 from 28 Apr 2025) - Snapshot on 30 Oct 2026

With bulls spooked by the sudden rapid deflation of some of the biggest companies in the AI tech sector after their earnings outlook shifted to be worst than expected, we can expect more outsize reactions as other companies report their earnings in the next few weeks. How stock prices will react will depend greatly on what new information investors will need to absorb from the newstreams. Much like they had to do with the market moving headlines from the final trading week of October 2026….

Monday, 26 October 2026
  • Signs and portents for the U.S. economy:
  • Fed minions expected to leave interest rates unchanged this week:
  • Some growth signs developing in China:
  • Bigger trouble, wage-price inflation spiral developing in Japan:
  • Bigger trouble developing in Eurozone:
  • Wall Street ends higher as AI capex fears pause, Fed decision looms
  • Tuesday, 27 October 2026
    • Signs and portents for the U.S. economy:
  • Hold or sell? High Treasury yields spur US banks to rethink bond portfolios
  • US new home sales fall in September; median house price drops from year ago
  • Fed minions hear speculation in media about their next moves:
  • Bigger trouble, mixed growth signs developing in China:
  • Former BOJ chief minion super excited for more interest rate hikes in Japan, JapanGov minion standing by to keep Japan’s currency from collapsing:
  • Bigger trouble developing in Eurozone:
  • Wall Street ends higher ahead of FOMC rate decision, big tech earnings
  • Wednesday, 28 October 2026
    • Signs and portents for the U.S. economy:
  • US goods trade deficit widens as AI-related demand pushes imports to record high
  • Walmart cuts holiday meal basket price to $3.50 per person
  • As expected, Fed minions leave U.S. interest rates unchanged, threaten future hikes:
  • Bigger trouble, stimulus developing in China:
  • Wall Street advances for the third consecutive session after the Fed keeps rates unchanged
  • Thursday, 29 October 2026
    • Signs and portents for the U.S. economy:
  • US inflation heats up in September; consumer spending rises
  • AI-related investment, consumers likely boosted US economic growth in third quarter
  • Oil falls as diplomacy hopes outweigh Middle East escalation fears
  • US weekly jobless claims hover near 57-year lows
  • Fed minions thinking about their balance sheet:
  • Bigger trouble developing in China:
  • Job hunting chief ECB minion to quit ECB early as ECB minions skip rate hike for now with plan to hike Eurozone interest rates later:
  • ECB flags December hike but sees yield rise hitting growth
  • Nasdaq sheds 1.4% as Alphabet’s historic drop rattles the markets, U.S. stocks suffer
  • Friday, 30 October 2026
    • Signs and portents for the U.S. economy:
  • Fed minions say inflation bad enough to justify rate hikes, but not until December 2026:
  • BOJ minions claim success in hitting their inflation target, thinking about more rate hikes later in year to contain it:
  • BOJ holds rates as underlying inflation aligns with 2% target for first time since 2013
  • Bigger trouble developing in Eurozone:
  • S&P 500 ends week lower as AI concerns fuel rotation into defensive sectors
  • Amazon burns cash, Intel flags weak PC demand as AI boom’s costs ripple across markets
  • Intel on course for worst day ever, triggers global chip rout
  • The CME Group’s FedWatch Tool projections were unchanged. It still anticipates the Fed will next act to hike the Federal Funds Rate by a quarter point on 9 December (2026-Q4). Looking further forward in time, the FedWatch tool projects the Fed will hike this interest rate by a quarter percent on 17 March (2027-Q1). After that, the FedWatch Tool anticipates one more rate hike in 2027, coming when the Fed meets on 15 September (2027-Q3).

    The Bureau of Economic Analysis reported its initial estimate for annualized real GDP growth during 2026-Q3 is +3.4%, just a bit lower than the +3.5% growth projected by the Atlanta Fed’s GDPNow tool a week before.

    The GDPNow tool has shifted forward to projecting the current quarter of 2026-Q4′s inflation-adjusted economic growth rate, with its first estimate for the quarter coming in at 3.2%.

    Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Wall Street bull taking cover under a table as a few balloons labeled ‘AI’ begin to pop while a smiling bear loads a dart labeled ‘COSTS’ into a blowgun”.



    Source: https://politicalcalculations.blogspot.com/2026/11/s-500-falls-as-investors-get-spooked-by.html


    Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

    Anyone can join.
    Anyone can contribute.
    Anyone can become informed about their world.

    "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

    Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


    LION'S MANE PRODUCT


    Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


    Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



    Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


    Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login